Market Closed -
Japan Exchange
11:30:00 26/04/2024 am IST
|
5-day change
|
1st Jan Change
|
410
JPY
|
+2.50%
|
|
+5.40%
|
-12.02%
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
10,87,401
|
5,57,406
|
7,65,586
|
4,79,930
|
3,21,807
|
1,62,889
|
-
|
-
|
Enterprise Value (EV)
1 |
9,37,295
|
7,24,961
|
8,16,227
|
5,45,994
|
5,24,701
|
4,55,213
|
4,65,681
|
4,71,758
|
P/E ratio
|
22.4
x
|
13.7
x
|
13.6
x
|
8.51
x
|
-4.32
x
|
-0.82
x
|
-3.34
x
|
-8.3
x
|
Yield
|
1.02%
|
2%
|
1.45%
|
2.32%
|
2.59%
|
-
|
-
|
-
|
Capitalization / Revenue
|
2.37
x
|
1.15
x
|
1.48
x
|
0.86
x
|
0.58
x
|
0.52
x
|
0.47
x
|
0.45
x
|
EV / Revenue
|
2.04
x
|
1.5
x
|
1.58
x
|
0.97
x
|
0.94
x
|
1.44
x
|
1.33
x
|
1.31
x
|
EV / EBITDA
|
13
x
|
7.21
x
|
8.69
x
|
5.54
x
|
9.11
x
|
-2.76
x
|
20.2
x
|
28.6
x
|
EV / FCF
|
23.8
x
|
-2.72
x
|
5.65
x
|
42.1
x
|
-13
x
|
-3.58
x
|
-17.6
x
|
-233
x
|
FCF Yield
|
4.21%
|
-36.8%
|
17.7%
|
2.37%
|
-7.72%
|
-27.9%
|
-5.69%
|
-0.43%
|
Price to Book
|
2.18
x
|
1.05
x
|
1.32
x
|
0.79
x
|
0.79
x
|
0.72
x
|
0.95
x
|
1.09
x
|
Nbr of stocks (in thousands)
|
3,97,297
|
3,97,295
|
3,97,294
|
3,97,293
|
3,97,292
|
3,97,291
|
-
|
-
|
Reference price
2 |
2,737
|
1,403
|
1,927
|
1,208
|
810.0
|
410.0
|
410.0
|
410.0
|
Announcement Date
|
10/05/19
|
13/05/20
|
12/05/21
|
13/05/22
|
15/05/23
|
-
|
-
|
-
|
Fiscal Period: März |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
4,59,267
|
4,82,732
|
5,15,952
|
5,60,035
|
5,55,544
|
3,16,260
|
3,49,728
|
3,59,056
|
EBITDA
1 |
71,860
|
1,00,604
|
93,897
|
98,582
|
57,627
|
-1,65,072
|
23,054
|
16,493
|
EBIT
1 |
57,884
|
83,239
|
71,224
|
60,234
|
-76,979
|
-2,00,985
|
-44,049
|
-15,766
|
Operating Margin
|
12.6%
|
17.24%
|
13.8%
|
10.76%
|
-13.86%
|
-63.55%
|
-12.6%
|
-4.39%
|
Earnings before Tax (EBT)
1 |
65,046
|
83,947
|
77,851
|
82,961
|
-47,920
|
-1,97,567
|
-47,130
|
-18,631
|
Net income
1 |
48,627
|
40,753
|
56,219
|
56,413
|
-74,512
|
-1,98,180
|
-48,695
|
-19,626
|
Net margin
|
10.59%
|
8.44%
|
10.9%
|
10.07%
|
-13.41%
|
-62.66%
|
-13.92%
|
-5.47%
|
EPS
2 |
122.4
|
102.6
|
141.5
|
142.0
|
-187.6
|
-498.8
|
-122.6
|
-49.40
|
Free Cash Flow
1 |
39,446
|
-2,66,556
|
1,44,476
|
12,961
|
-40,482
|
-1,27,120
|
-26,484
|
-2,027
|
FCF margin
|
8.59%
|
-55.22%
|
28%
|
2.31%
|
-7.29%
|
-40.19%
|
-7.57%
|
-0.56%
|
FCF Conversion (EBITDA)
|
54.89%
|
-
|
153.87%
|
13.15%
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
81.12%
|
-
|
256.99%
|
22.98%
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
28.00
|
28.00
|
28.00
|
28.00
|
21.00
|
-
|
-
|
-
|
Announcement Date
|
10/05/19
|
13/05/20
|
12/05/21
|
13/05/22
|
15/05/23
|
-
|
-
|
-
|
Fiscal Period: March |
2020 S1
|
2020 S2
|
2021 S1
|
2022 Q2
|
2022 S1
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 S1
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 S1
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
2025 S1
|
2025 Q3
|
2025 Q4
|
2026 S1
|
---|
Net sales
1 |
2,30,603
|
2,52,129
|
2,61,498
|
1,62,534
|
2,93,730
|
1,38,342
|
1,27,963
|
1,59,876
|
1,59,400
|
3,19,300
|
1,40,976
|
-
|
75,700
|
76,942
|
1,52,642
|
82,386
|
79,948
|
81,269
|
-
|
1,66,420
|
-
|
-
|
1,77,456
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-21,646
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
66,835
|
16,404
|
47,539
|
39,266
|
47,572
|
10,656
|
2,006
|
14,614
|
-43,500
|
-28,900
|
11,138
|
-
|
-51,600
|
-34,898
|
-86,498
|
-31,247
|
-51,031
|
-18,664
|
-
|
-36,422
|
-
|
-
|
-9,217
|
Operating Margin
|
28.98%
|
6.51%
|
18.18%
|
24.16%
|
16.2%
|
7.7%
|
1.57%
|
9.14%
|
-27.29%
|
-9.05%
|
7.9%
|
-
|
-68.16%
|
-45.36%
|
-56.67%
|
-37.93%
|
-63.83%
|
-22.97%
|
-
|
-21.89%
|
-
|
-
|
-5.19%
|
Earnings before Tax (EBT)
1 |
64,147
|
19,800
|
43,654
|
41,309
|
49,266
|
16,317
|
17,378
|
46,610
|
-25,610
|
21,000
|
-18,842
|
-
|
-31,100
|
-25,027
|
-56,127
|
-49,064
|
-75,454
|
-18,754
|
-
|
-36,602
|
-
|
-
|
-9,397
|
Net income
1 |
30,330
|
10,423
|
37,297
|
31,650
|
36,450
|
9,909
|
10,054
|
31,108
|
-38,400
|
-7,300
|
-11,219
|
-
|
-38,900
|
-28,841
|
-67,741
|
-49,967
|
-64,418
|
-14,065
|
-
|
-27,452
|
-
|
-
|
-7,048
|
Net margin
|
13.15%
|
4.13%
|
14.26%
|
19.47%
|
12.41%
|
7.16%
|
7.86%
|
19.46%
|
-24.09%
|
-2.29%
|
-7.96%
|
-
|
-51.39%
|
-37.48%
|
-44.38%
|
-60.65%
|
-80.58%
|
-17.31%
|
-
|
-16.5%
|
-
|
-
|
-3.97%
|
EPS
2 |
76.34
|
-
|
93.88
|
79.66
|
91.75
|
24.94
|
25.30
|
78.30
|
-96.63
|
-18.33
|
-28.24
|
-141.0
|
-97.82
|
-72.69
|
-170.5
|
-125.8
|
-266.3
|
-35.40
|
-
|
-69.10
|
-
|
-
|
-17.70
|
Dividend per Share
2 |
14.00
|
-
|
14.00
|
-
|
14.00
|
-
|
-
|
-
|
-
|
14.00
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
28/10/19
|
13/05/20
|
28/10/20
|
27/10/21
|
27/10/21
|
31/01/22
|
13/05/22
|
29/07/22
|
31/10/22
|
31/10/22
|
31/01/23
|
15/05/23
|
31/07/23
|
31/10/23
|
31/10/23
|
31/01/24
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
1,67,555
|
50,641
|
66,064
|
2,02,894
|
2,92,323
|
3,02,792
|
3,08,869
|
Net Cash position
1 |
1,50,106
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
1.665
x
|
0.5393
x
|
0.6701
x
|
3.521
x
|
-1.771
x
|
13.13
x
|
18.73
x
|
Free Cash Flow
1 |
39,446
|
-2,66,556
|
1,44,476
|
12,961
|
-40,482
|
-1,27,121
|
-26,484
|
-2,027
|
ROE (net income / shareholders' equity)
|
10.2%
|
7.9%
|
10.1%
|
9.5%
|
-14.7%
|
-59.2%
|
-18.7%
|
-6.58%
|
ROA (Net income/ Total Assets)
|
7.91%
|
8.04%
|
4.38%
|
6.34%
|
-3.92%
|
-19.9%
|
-2.96%
|
-2.79%
|
Assets
1 |
6,14,659
|
5,06,723
|
12,83,539
|
8,89,478
|
18,99,145
|
9,94,132
|
16,45,849
|
7,02,755
|
Book Value Per Share
2 |
1,254
|
1,333
|
1,461
|
1,530
|
1,024
|
571.0
|
432.0
|
378.0
|
Cash Flow per Share
2 |
158.0
|
146.0
|
199.0
|
239.0
|
-83.70
|
-302.0
|
-209.0
|
71.90
|
Capex
1 |
9,265
|
7,722
|
6,048
|
7,347
|
14,600
|
14,080
|
12,280
|
12,280
|
Capex / Sales
|
2.02%
|
1.6%
|
1.17%
|
1.31%
|
2.63%
|
4.45%
|
3.51%
|
3.42%
|
Announcement Date
|
10/05/19
|
13/05/20
|
12/05/21
|
13/05/22
|
15/05/23
|
-
|
-
|
-
|
Mean consensus UNDERPERFORM Average target price
333.8
JPY Spread / Average Target -18.60% Consensus |
1st Jan change
|
Capi.
|
---|
| -12.02% | 1.03B | | +25.83% | 661B | | +27.00% | 566B | | -6.76% | 352B | | +20.34% | 332B | | +3.00% | 283B | | +13.09% | 231B | | +5.46% | 200B | | -9.61% | 195B | | -6.26% | 145B |
Other Pharmaceuticals
|